Amy L. Inselman Source Confirmed

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Research Biologist

National Center for Toxicological Research

faculty

14 h-index 46 pubs 987 cited

Is this your profile? Verify and claim your profile

Biography and Research Information

OverviewAI-generated summary

Amy L. Inselman's research focuses on the study of toxicological effects and the development of preclinical models for drug evaluation. She has investigated the influence of coadministered compounds, such as black cohosh extract and risedronate, on bone health in ovariectomized rat models. Her work also involves utilizing advanced techniques like MALDI mass spectrometry imaging to identify biomarkers of toxicity following in utero opioid exposures in mouse fetuses. Inselman has published on the benefits, limitations, and opportunities presented by preclinical models in the field of neonatal drug development. Her scholarship metrics include an h-index of 14, with 46 total publications and 987 total citations. She has collaborated with researchers at the National Center for Toxicological Research, including Richard D. Beger and E. Ellen Jones.

Metrics

  • h-index: 14
  • Publications: 46
  • Citations: 987

Selected Publications

  • The incorporation of MALDI mass spectrometry imaging in studies to identify markers of toxicity following in utero opioid exposures in mouse fetuses (2024) DOI
  • The effect of black cohosh extract and risedronate coadministration on bone health in an ovariectomized rat model (2024) DOI
  • The benefits, limitations and opportunities of preclinical models for neonatal drug development (2022) DOI

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics